More search options
We are looking in more than 100 shops for your best offer - please wait…
- Shipping costs to Ethiopia (modify to GBR, AUS, NZL, IND, MOZ, AGO, NAM, KEN, KEN, TZA, TZA, GHA, MWI)
Create preset

All books for 9783319343129 - compare every offer

9783319343129 - Springer: Optimization of Pharmaceutical R&D Programs and Portfolios - Book
1
Springer (?):

Optimization of Pharmaceutical R&D Programs and Portfolios (?)

Delivery from: SwitzerlandBook is in english languageNew book

ISBN: 9783319343129 (?) or 3319343122, in english, New

121.76 (Fr. 131.90)¹ + Shipping: 13.85 (Fr. 15.00)¹ = 135.61 (Fr. 146.90)¹(without obligation)
plus shipping, Versandfertig innert 3 Wochen
From Seller/Antiquarian
Design and Investment Strategy, Very little has been published on optimization of pharmaceutical portfolios. Moreover, most of published literature is coming from the commercial side, where probability of technical success (PoS) is treated as fixed, and not as a consequence of development strategy or design. In this book there is a strong focus on impact of study design on PoS and ultimately on the value of portfolio. Design options that are discussed in different chapters are dose-selection strategies, adaptive design and enrichment. Some development strategies that are discussed are indication sequencing, optimal number of programs and optimal decision criteria. This book includes chapters written by authors with very broad backgrounds including financial, clinical, statistical, decision sciences, commercial and regulatory. Many authors have long held executive positions and have been involved with decision making at a product or at a portfolio level. As such, it is expected that this book will attract a very broad audience, including decision makers in pharmaceutical R&D, commercial and financial departments. The intended audience also includes portfolio planners and managers, statisticians, decision scientists and clinicians. Early chapters describe approaches to portfolio optimization from big Pharma and Venture Capital standpoints. They have stronger focus on finances and processes. Later chapters present selected statistical and decision analysis methods for optimizing drug development programs and portfolios. Some methodological chapters are technical; however, with a few exceptions they require a relatively basic knowledge of statistics by a reader.
Seller order number: 46025463
Platform order number Buch.ch: 2f67962355db3bd7deaae2d0086e5ee9
Category: Bücher / Fremdsprachige Bücher / Englische Bücher
Keywords: Bücher
Data from 08/03/2016 18:59h
ISBN (alternative notations): 3-319-34312-2, 978-3-319-34312-9

9783319343129

Find all available books for your ISBN number 9783319343129 compare prices fast and easily and order immediatly.

Available rare books, used books and second hand books of the title "Optimization of Pharmaceutical R&D Programs and Portfolios" from Springer are completely listed.

Books nearby

>> to Archive